officially retracts the article entitled, “Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer” by Zhaofeng Tan, Yuli Sun, Mei Liu, Lei Xia, Fang Cao, Yuanfu Qi, and Yonglei Song, (Cancer Biother Radiopharm; E-pub 27 Jun 2020; doi: 10.1089/cbr.2019.3520) at the authors' request:
“...we feel that we have not yet studied our work completely and some new great results are discovered. So after carefully thinking, we are going to rearrange this manuscript and try to give more precise model. Thus we decided to withdraw this manuscript with great pity. We sincerely say sorry for all the staffs involved this manuscript including editors, reviewers etc. because of our action.”[sic]
After careful consideration, the Editor agreed to retract the paper.
The Editor and Publisher of Cancer Biotherapy and Radiopharmaceuticals are committed to preserving the scientific literature and the community it serves.
Get full access to this article
View all access options for this article.
References
1.
SiegelRL, MillerKD, JemalA. Cancer statistics, 2017. CA Cancer J Clin, 2017; 67:1.
2.
MartinP, LeighlNB. Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice. Ther Adv Med Oncol, 2017; 9:6.
3.
SangodkarJ, KatzS, MelvilleH, et al.Lung adenocarcinoma: Lessons in translation from bench to bedside. Mt Sinai J Med, 2010; 77:6.
4.
Al-RejaieSS, AleisaAM, AbuohashishHM, et al.Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurol Res, 2015; 37:10.
5.
MartinezRM, Pinho-RibeiroFA, SteffenVS, et al.Naringenin inhibits UVB irradiation-induced inflammation and oxidative stress in the skin of hairless mice. J Nat Prod, 2015; 78:7.
6.
ZhaoZ, JinG, GeY, et al.Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology, 2019; 27:5.
7.
HanKY, ChenPN, HongMC, et al.Naringenin attenuated prostate cancer invasion via reversal of epithelial-to-mesenchymal transition and inhibited uPA activity. Anticancer Res, 2018; 38:12.
8.
ChenYY, ChangYM, WangKY, et al.Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms. Environ Toxicol, 2019; 34:3.
9.
SuQ, LvX. Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics, 2020; 112:1680.
10.
ZhuK, HuX, ChenH, et al.Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine, 2019; 49:341.
11.
LiuZ, YuY, HuangZ, et al.CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis, 2019; 10:12.
12.
TangQ, ChenZ, ZhaoL. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY), 2019; 11:9982.
13.
LuH, HanX, RenJ, et al.Circular RNA HIPK3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging miR-149. Cancer Biol Ther, 2020; 21:113.
14.
XueYB, DingMQ, XueL, et al.CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression. Thorac Cancer, 2019; 10:8.
15.
MaX, YangX, BaoW, et al.Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis. Biochem Biophys Res Commun, 2018; 498:4.
16.
WangR, ZhangS, ChenX, et al.EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol Cancer, 2018; 17:1.
17.
PanY, XuT, LiuY, et al.Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem Biophys Res Commun, 2019; 510:2.
18.
LiX, YangL, ChenLL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell, 2018; 71:3.
19.
ShaoC, YangF, QinZ, et al.The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: A systematic review with meta-analysis. BMC Cancer, 2019; 19:1.
20.
FengQ, ZhangH, NieX, et al.miRNA-149* suppresses liver cancer progression by down-regulating TRADD protein expression. Am J Pathol, 2020; 190:469.
21.
LiS, WangC, YuX, et al.miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression. Oncol Rep, 2017; 37:1.
22.
ZhangQ, MiaoS, HanX, et al.microRNA-3619-5p suppresses bladder carcinoma progression by directly targeting beta-catenin and CDK2 and activating p21. Cell Death Dis, 2018; 9:10.
23.
NiuX, LiuS, JiaL, et al.Role of miR-3619-5p in beta-catenin-mediated non-small cell lung cancer growth and invasion. Cell Physiol Biochem, 2015; 37:4.
24.
SongL, DaiZ, ZhangS, et al.MicroRNA-1179 suppresses cell growth and invasion by targeting sperm-associated antigen 5-mediated Akt signaling in human non-small cell lung cancer. Biochem Biophys Res Commun, 2018; 504:1.
25.
WuY, NiuY, LengJ, et al.Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673. Toxicol Lett, 2020; 320:37.
26.
LiaoAC, KuoCC, HuangYC, et al.Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP2. Mol Med Rep, 2014; 10:3.
27.
LouC, ZhangF, YangM, et al.Naringenin decreases invasiveness and metastasis by inhibiting TGF-beta-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS One, 2012; 7:12.
28.
ChangHL, ChangYM, LaiSC, et al.Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9. Exp Ther Med, 2017; 13:2.
29.
LiuG, ShiH, DengL, et al.Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer. Biochem Biophys Res Commun, 2019; 513:1.
30.
KangY, MassagueJ. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell, 2004; 118:3.
31.
ThieryJP, AcloqueH, HuangRY, et al.Epithelial-mesenchymal transitions in development and disease. Cell, 2009; 139:5.
32.
WangP, HeX. Current research on circular RNAs associated with colorectal cancer. Scand J Gastroenterol, 2017; 52:11.
33.
ZhangM, LuoH, HuiL. miR-3619-5p hampers proliferation and cisplatin resistance in cutaneous squamous-cell carcinoma via KPNA4. Biochem Biophys Res Commun, 2019; 513:2.
34.
NiuX, LiuS, JiaL, et al.Role of MiR-3619-5p in β-catenin-mediated non-small cell lung cancer growth and invasion. Cell Physiol Biochem, 2015; 37:4.
35.
YuanLJ, LiJD, ZhangL, et al.SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway. Cell Death Dis, 2014; 5:e1247.
36.
LiuH, HuJ, WeiR, et al.SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying beta-catenin degradation. J Exp Clin Cancer Res, 2018; 37:1.
